Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)

BACKGROUND: The aim of our analysis is to further characterise the prognostic relevance of early tumour shrinkage (TS) during VEGF-targeted therapy in mRCC, in order to explore whether this could define a group of patients with long-term survivorship. METHODS: A hundred patients were stratified into...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, C, Busch, J, Weikert, S, Steffens, S, Bokemeyer, C, Grünwald, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859945/
https://www.ncbi.nlm.nih.gov/pubmed/24169357
http://dx.doi.org/10.1038/bjc.2013.662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859945/
https://www.ncbi.nlm.nih.gov/pubmed/24169357
http://dx.doi.org/10.1038/bjc.2013.662

Ejemplares similares